Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

EHC vs ENSG: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

EHC Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 9–1 Matrix Metrics)

EHC Overall Winner 6-Pillar Tally: EHC 4 – 2 ENSG Matrix Metrics: EHC 9 – 1 ENSG

As of Nov 20, 2026, Encompass Health Corporation (EHC) is the stronger overall head-to-head candidate over The Ensign Group, Inc. (ENSG) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). EHC carries a Unified Composite Score of 52.0/100 (HOLD) at $133.65 (19.4x Forward P/E, 18.4% operating margin), whereas ENSG carries 48.3/100 (HOLD) at $176.32 (20.1x Forward P/E, 8.8% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About EHC vs ENSG
EHC NYSE Head-to-Head Winner
Encompass Health Corporation Common Stock
Services-Hospitals
$133.65
+1.04% 1D
Market Cap $13.0B
TTM Revenue $6.34B
Forward P/E 19.4x
Beta / 30D Vol -0.10β · 40% Vol
Unified Composite Score
52.0 / 100 HOLD
Tech 40.0 Fund 47.0 Flow 54.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 50
RSI-14: 49.8 · SMA20: $135.78 · SMA50: $128.15
ENSG NASDAQ
The Ensign Group, Inc.
Services-Skilled Nursing Care Facilities
$176.32
-0.15% 1D
Market Cap $10.3B
TTM Revenue $5.67B
Forward P/E 20.1x
Beta / 30D Vol 0.12β · 42% Vol
Unified Composite Score
48.3 / 100 HOLD
Tech 45.0 Fund 54.0 Flow 67.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 44
RSI-14: 43.5 · SMA20: $182.49 · SMA50: $177.52

6-Pillar Scorecard Institutional Category Breakdown (EHC 4 – 2 ENSG)

Columns: Metric · EHC · ENSG
1. Valuation Multiples EHC
Forward P/E 19.4x 20.1x
Trailing P/E 21.2x 26.3x
PEG Ratio 0.41x 1.40x
EV / Revenue 2.5x 2.2x
2. Growth & Scale ENSG
Revenue Growth (YoY) +8.9% +14.5%
Earnings Growth (YoY) +21.6% +23.9%
TTM Revenue (USD) $6.34B $5.67B
Market Cap $13.0B $10.3B
3. Profitability & Quality EHC
Gross Margin 44.1% 17.1%
Operating Margin 18.4% 8.8%
Net Profit Margin 10.2% 7.0%
Return on Equity (ROE) 25.1% 17.1%
4. Balance Sheet & Cash Flow EHC
Cash Generation (TTM) $457M $210M
Cash Flow Margin 7.2% 3.7%
Net Cash / Leverage $2.73B Net Debt (1.05x D/E) $1.95B Net Debt (0.89x D/E)
Dividend Yield 0.58% 0.14%
5. Options & Positioning ENSG
Options Structure Phase CONSOLIDATION CONSOLIDATION
Current IV / %ile 27.0% (8th %ile) 99.5% (62nd %ile)
Put/Call OI Skew 0.25x (Call-Skewed) N/A
OBV Trend / Tech Phase DISTRIBUTION · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat EHC
OpEx & R&D Intensity 25.7% of Rev ($1.63B) 8.3% of Rev ($471M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Care Facilities Operator Medical Care Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: EHC (9) vs ENSG (1)
Institutional Metric EHC ENSG Criterion Row Edge
Market Capitalization
Scale
$13.0B $10.3B Larger Scale EHC
Trailing P/E Ratio
Valuation
21.2x 26.3x Lower Multiple EHC
Forward P/E Ratio
Valuation
19.4x 20.1x Lower Multiple EHC
Revenue Growth (YoY)
Growth
+8.9% +14.5% Higher Growth ENSG
Operating Margin (TTM)
Profitability
18.4% 8.8% Higher Margin EHC
Net Profit Margin
Profitability
10.2% 7.0% Higher Margin EHC
Return on Equity (ROE)
Capital Efficiency
25.1% 17.1% Higher ROE EHC
52-Week Range Position
Momentum
80% ($93–$144) 46% ($142–$218) Stronger Trend EHC
Beta / 30D Volatility
Risk Regime
-0.10β · 40% Vol 0.12β · 42% Vol Lower Realized Risk EHC
Unified Institutional Score
Composite Signal
52.0 / 100 (HOLD) 48.3 / 100 (HOLD) Higher Composite EHC
Trailing 12M Revenue (USD)
Operating Scale
$6.34B $5.67B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
44.1% 17.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.41x PEG · 2.5x EV/Rev 1.40x PEG · 2.2x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$457M ($2.73B Net Debt (1.05x D/E)) $210M ($1.95B Net Debt (0.89x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon EHC +7.2 pp
EHC: +6.06% · ENSG: -1.14%
3M Horizon EHC +12.23 pp
EHC: +10.53% · ENSG: -1.7%
6M Horizon EHC +24.78 pp
EHC: +27.33% · ENSG: +2.55%
1Y Horizon EHC +20.76 pp
EHC: +19.42% · ENSG: -1.34%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period EHC Revenue ENSG Revenue EHC Op. Margin ENSG Op. Margin Margin Leader
FY2018 $4.28B $1.75B 13.0% 4.8% EHC
FY2019 $4.61B $2.04B 13.3% 6.3% EHC
FY2020 $3.57B $2.39B 15.8% 9.3% EHC
FY2021 $4.01B $2.63B 13.9% 9.9% EHC
FY2022 $4.35B $3.03B 12.4% 9.8% EHC
FY2023 $4.80B $3.71B 7.3% 6.9% EHC
FY2024 $5.37B $4.24B 8.5% 8.5% Tie
FY2025 $5.94B $5.03B 9.5% 8.5% EHC

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
EHC CONSOLIDATION
73d in phase · OBV DISTRIBUTION
Current IV 27.0%
IV Percentile 8th %ile
Put/Call OI Skew 0.25x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact EHC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ENSG CONSOLIDATION
73d in phase · OBV NEUTRAL
Current IV 99.5%
IV Percentile 62nd %ile
Put/Call OI Skew N/A
IV Regime Elevated (60th–80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact ENSG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
EHC Moat Profile Scale & Operating Efficiency Moat
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $13.0B market capitalization and 18.4% operating margin.
OpEx & R&D Reinvestment 25.7% of Rev ($1.63B)
90D Engineering Disclosures 0 Published
ENSG Moat Profile Cyclical / Execution-Driven Positioning
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $10.3B market capitalization and 8.8% operating margin.
OpEx & R&D Reinvestment 8.3% of Rev ($471M)
90D Engineering Disclosures 0 Published

Investor FAQ EHC vs ENSG Key Questions & Quantitative Answers

As of Nov 20, 2026, Encompass Health Corporation (EHC) is the stronger overall head-to-head candidate over The Ensign Group, Inc. (ENSG) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). EHC carries a Unified Composite Score of 52.0/100 (HOLD) at $133.65 (19.4x Forward P/E, 18.4% operating margin), whereas ENSG carries 48.3/100 (HOLD) at $176.32 (20.1x Forward P/E, 8.8% operating margin). Technically, EHC sits in a Neutral phase (RSI 49.8, CONSOLIDATION options structure) and ENSG sits in a Neutral phase (RSI 43.5, CONSOLIDATION options structure).

ENSG leads the Growth & Scale pillar: EHC posts +8.9% YoY revenue growth and +21.6% YoY earnings growth on $6.34B TTM revenue (44.1% gross margin, 18.4% operating margin), compared with ENSG at +14.5% YoY revenue growth and +23.9% YoY earnings growth on $5.67B TTM revenue (17.1% gross margin, 8.8% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), EHC cumulative revenue shifted +38.8% while ENSG shifted +187.4%. In operating R&D and SG&A reinvestment, EHC deploys 25.7% of Rev ($1.63B) (0 90-day corporate R&D disclosures) versus 8.3% of Rev ($471M) (0 disclosures) for ENSG.

EHC screens cheaper on headline valuation multiples. EHC trades at 19.4x Forward P/E, 21.2x Trailing P/E, 0.41x PEG, and 2.5x EV/Revenue (7.2% FCF margin), whereas ENSG trades at 20.1x Forward P/E, 26.3x Trailing P/E, 1.40x PEG, and 2.2x EV/Revenue (3.7% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against EHC (25.1% ROE) versus ENSG (17.1% ROE) capital efficiency.

In options market volatility and institutional positioning, EHC carries 27.0% implied volatility (8th %ile, Compressed (<25th %ile)), a 0.25x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.10β · 40% Vol realized risk). By comparison, ENSG carries 99.5% implied volatility (62nd %ile, Elevated (60th–80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.12β · 42% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.